Home |  Contact Us | Site Map

Investor Relations

Corporate Profile

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

NASDAQ: BCRX
$3.08 + 0.10
Jul 22, 2016 at 4:00 PM ET
Intraday data provided by eSignal

Recent Releases View All Releases

BioCryst to Announce Second Quarter 2016 Financial Results August 4
RESEARCH TRIANGLE PARK, N.C., July 21, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its second quarter...

Read More

BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases
RESEARCH TRIANGLE PARK, N.C., July 05, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Insti...

Read More

Investor Relations

Rob Bennett, Vice President Investor Relations & Operations
919.859.7910
investorrelations@biocryst.com

Proxy Online

For more information click here.

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)